Ir al contenido principal

Manuel Elkin Patarroyo, an influential Colombian

Physical Description


He is Manuel Elkin Patarroyo.
El espectador. (2014, Sep 30). Retrieved from Hace 27 años Manuel Elkin Patarroyo creó la primera vacuna contra la malaria: https://www.google.com.co/imgres?imgurl=https://www.elespectador.com/sites/default/files/b1530fe4d44dafce395c581129e9869a.jpg&imgrefurl=https://www.elespectador.com/



Dr. Manuel Elkin works in a laboratory. He is very friendly but very professional. He loves his profession, he is passionate about medicine. He is elderly but healthy. He has a white skin and is medium height. He has gray-haired and has brown eyes. Usually, he is smiling. In this picture he is wearing a purple sweater and under it he is wearing a white bottom shirt. He is wearing black slacks with black shoes. His style is classic and elegant in other situations.

Personal Information


Age: 71 years old (Ataco, Tolima, 3th, November of 1949)
Nationality: Colombian
Place of birth: Born in the municipality of Ataco in the department of Tolima (Colombia)
Occupation: Scientific

First days and studies



He was born in the municipality of Ataco in the department of Tolima in Colombia with 13 brothers. He finished his baccalaureate studies at the José Max León School in Bogotá, Colombia. He entered the Faculty of Medicine of the National University of Colombia where he obtained his degree in 1971.That year he married pediatrician María Cristina Gutiérrez, with whom he had three children, two of whom, also work in medicine.
Between 1986 and 1988 the vaccine against malaria was created by Manuel Elkin Patarroyo and successfully tested in a colony of monkeys from the Amazon region, the Aotus Trivirgatus and in a group of young volunteer high school graduates who performed their military service.
Since childhood Patarroyo felt admiration for the figure of Louis Pasteur and a great interest in immunology and virology, so that his professional career was oriented to research in various national and foreign centers, particularly American and Swedish.
In 1983, his team began work on malaria, and immediately achieved a great achievement: obtaining, in 1984, a synthetic vaccine (SPF-66) against the disease, which would later be refined to reach powerful levels of effectiveness.


Comentarios